Jump to content

Taper rates for short duration exposure (<3 weeks)


DoctorMussyWasHere

Recommended Posts

Hi All, it's been a while. Hope all is good.

 

Can I get some advice on what taper rate to choose for someone who had their dose doubled

and after two weeks wants to return to something approaching the previous dose?

 

 

In this case the person is a 42-year-old woman who has been on various ADs for 10 years, 30mg Duloxetine for the past few years.

Additionally there's a dependance on Xanax and Zolpidem.

 

A psychiatrist told them they'd be able to get free from the benzo and z-drug with the increased duloxetine,

but said she'd need to be on the duloxetine for life.

 

Two weeks down the line she's experiencing side effects and not much effect.

Never having really believed in ADs in the first place the placebo magic has never been accessible to her.

 

 

So she has been on 60mg Duloxetine for two weeks.

Can this be tapered a little faster to skip the years-long taper requirement back down to 30mg?

 

Many thanks,

DM

I am here as a supporter to certain individuals undergoing withdrawal, and to learn from and contribute to the forum where possible.
Link to comment
Share on other sites

  • ChessieCat changed the title to Taper rates for short duration exposure (<3 weeks)
  • Administrator

Hi, DoctorM.

 

If this person went from 30mg to 60mg only two weeks ago, she can back down to 30mg right off.

 

If she's been taking at least 30mg for more than a month, a more gradual taper from 30mg is advisable.

This is not medical advice. Discuss any decisions about your medical care with a knowledgeable medical practitioner.

"It has become appallingly obvious that our technology has surpassed our humanity." -- Albert Einstein

All postings © copyrighted.

Link to comment
Share on other sites

That's a big relief, Alto. Thanks so much.. will pass that on..

I am here as a supporter to certain individuals undergoing withdrawal, and to learn from and contribute to the forum where possible.
Link to comment
Share on other sites

×
×
  • Create New...

Important Information

Terms of Use Privacy Policy